
PMC:7373848 / 28416-29026
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T489 | 231-246 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
T490 | 476-486 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
T491 | 505-513 | Body_part | denotes | monocyte | http://purl.org/sig/ont/fma/fma62864 |
T492 | 549-558 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T493 | 582-586 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
550 | 324-328 | Gene | denotes | ACE2 | Gene:59272 |
551 | 302-312 | Species | denotes | SARS–COV-2 | Tax:2697049 |
552 | 207-214 | Chemical | denotes | aspirin | MESH:D001241 |
553 | 0-16 | Disease | denotes | Kawasaki Disease | MESH:D009080 |
554 | 18-20 | Disease | denotes | KD | MESH:C537017 |
555 | 287-295 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T139 | 0-16 | Disease | denotes | Kawasaki Disease | http://purl.obolibrary.org/obo/MONDO_0012727 |
T140 | 18-20 | Disease | denotes | KD | http://purl.obolibrary.org/obo/MONDO_0012727 |
T141 | 287-295 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T142 | 302-306 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T489 | 163-168 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T490 | 353-363 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T491 | 384-394 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T492 | 505-513 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocyte |
T493 | 574-575 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T494 | 580-586 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T189 | 18-20 | Chemical | denotes | KD | http://purl.obolibrary.org/obo/CHEBI_73601 |
T190 | 152-162 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T112 | 40-62 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune response |
T113 | 47-62 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T247 | 0-82 | Sentence | denotes | Kawasaki Disease (KD) follows an excess innate immune response to viral pathogens. |
T248 | 83-252 | Sentence | denotes | Several investigators have proposed involvement of the stimulator of interferon genes (STING) pathway inhibited upstream by aspirin and intravenous immunoglobulins [76]. |
T249 | 253-364 | Sentence | denotes | The same mechanism may operate in COVID-19 where SARS–COV-2 binding to ACE2 increases STING pathway activation. |
T250 | 365-610 | Sentence | denotes | In most instances, activation occurs during the second phase of illness with immune hyper-responses, decreased lymphocyte counts, increased monocyte populations that secrete cytotoxic cytokines and heightened B and T cell responses as well [77]. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T892 | 40-46 | GO:0045087 | denotes | innate |
T893 | 47-53 | GO:0045087;UBERON:0002405 | denotes | immune |
T894 | 54-62 | GO:0009615 | denotes | response |
T895 | 66-71 | NCBITaxon:10239 | denotes | viral |
T896 | 163-168 | SO:0000704 | denotes | genes |
T897 | 170-175 | PR:000016417 | denotes | STING |
T898 | 231-246 | GO:0019814 | denotes | immunoglobulins |
T899 | 287-295 | SP_7 | denotes | COVID-19 |
T900 | 302-312 | SP_7 | denotes | SARS–COV-2 |
T901 | 324-328 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T902 | 339-344 | PR:000016417 | denotes | STING |
T903 | 442-448 | UBERON:0002405 | denotes | immune |
T904 | 476-486 | CL:0000542 | denotes | lymphocyte |
T905 | 505-513 | CL:0000576 | denotes | monocyte |
T906 | 531-538 | GO:0046903 | denotes | secrete |
T907 | 574-575 | CL:0000236 | denotes | B |
T908 | 580-586 | CL:0000084;GO:0042110 | denotes | T cell |
T909 | 587-596 | GO:0042110 | denotes | responses |
T17675 | 40-46 | GO:0045087 | denotes | innate |
T66309 | 47-53 | GO:0045087;UBERON:0002405 | denotes | immune |
T58540 | 54-62 | GO:0009615 | denotes | response |
T46348 | 66-71 | NCBITaxon:10239 | denotes | viral |
T32366 | 163-168 | SO:0000704 | denotes | genes |
T56584 | 170-175 | PR:000016417 | denotes | STING |
T29437 | 231-246 | GO:0019814 | denotes | immunoglobulins |
T42958 | 287-295 | SP_7 | denotes | COVID-19 |
T6056 | 302-312 | SP_7 | denotes | SARS–COV-2 |
T12955 | 324-328 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T10255 | 339-344 | PR:000016417 | denotes | STING |
T5446 | 442-448 | UBERON:0002405 | denotes | immune |
T29332 | 476-486 | CL:0000542 | denotes | lymphocyte |
T56101 | 505-513 | CL:0000576 | denotes | monocyte |
T17042 | 531-538 | GO:0046903 | denotes | secrete |
T91170 | 574-575 | CL:0000236 | denotes | B |
T33978 | 580-586 | CL:0000084;GO:0042110 | denotes | T cell |
T73877 | 587-596 | GO:0042110 | denotes | responses |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32700024-32377375-64991499 | 606-608 | 32377375 | denotes | 77 |